Recessive Dystrophic Epidermolysis Bullosa Treatment Gets FDA's Priority Review
The FDA has accepted for Priority Review the BLA for pz-cel (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa.
Source: empr.com
Page 46 - Breakthrough Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Breakthrough Therapy Today - Breaking & Trending Today
Arkansas runs low on RSV vaccines for babies as cases rise
TEXARKANA, Ark. – This year, a shot was approved for babies to combat RSV (respiratory syncytial virus).
Source: ktbs.com
High demand and limited supply lead to RSV vaccine shortage amid flu season
The highly recommended R-S-V vaccine is becoming more challenging for to find.Parents who have been turned away are frustrated as we step into flu season as mos
Source: wsbt.com
Interview: The processes and difficulties of working within rare diseases
OSP was delighted to speak to Galina Nesterova, executive medical director at the Rare Disease & Pediatrics Center of Excellence, and Susan McKune, vice president of pediatrics and clinical pharmacology both within medical science and strategy at PPD, part of Thermo Fisher. They answered some pertinent questions surrounding rare diseases.
Source: outsourcing-pharma.com
CDC releases more RSV vaccines as cases spike in some states
U.S. health officials said Thursday they will be releasing more vaccines forrespiratory syncytial virus, or RSV, as cases spike in some parts of the country.
Source: kfdm.com